The Dark Side of Weight Loss Drugs: Blindness and Beyond
GLP-1 receptor drugs like Ozempic and Wegovy have become cultural phenomena, lauded by celebrities and increasingly prescribed for both type 2 diabetes and weight management. However, a growing number of reports are surfacing detailing frightening side effects, prompting lawsuits and raising serious questions about the long-term safety of these medications.
From Diabetes Treatment to Weight Loss Sensation
Originally developed as treatments for type 2 diabetes, GLP-1 agonists mimic a naturally occurring hormone that regulates blood sugar and appetite. The drugs perform by slowing stomach emptying, increasing insulin release, and decreasing glucagon secretion. It was the discovery of significant weight loss as a side effect that propelled drugs like Ozempic and Wegovy into the spotlight.
A Devastating Diagnosis: Vision Loss
Former truck driver Todd Engel, 63, from Maryland, is one of several individuals who have filed lawsuits against Novo Nordisk, the manufacturer of Ozempic and Wegovy. Engel developed non-arteritic anterior ischemic optic neuropathy (NAION) in both eyes after starting Ozempic in 2023, resulting in permanent blindness. He stated he would never have taken the drug had he known the potential risk.
Engel isn’t alone. Diane Wirth is as well suing Novo Nordisk after experiencing NAION in her right eye, forcing her retirement after a 30-year nursing career. Another lawsuit was filed by Tracy Ettinghoff after his wife, Marsha, passed away six months after starting Ozempic.
Novo Nordisk Responds
Novo Nordisk acknowledges the reports of adverse events and states that patient safety is their top priority. The company has updated the labels for Wegovy, Ozempic, and Rybelsus to include NAION as a potential side effect, classifying it as a “remarkably rare” occurrence (affecting up to 1 in 10,000 people). However, Novo Nordisk maintains that data does not suggest a causal relationship between semaglutide and NAION, and believes the benefit-risk profile remains favorable.
Common Side Effects: Beyond Vision Loss
While the reports of blindness are particularly alarming, other common side effects of Ozempic and Wegovy include nausea, diarrhea, abdominal pain, constipation, vomiting, headache, dizziness, fatigue, and heartburn. These side effects are generally mild to moderate, but can be disruptive to daily life.
The Rise of Oral GLP-1s: A New Option?
Until recently, GLP-1 medications were primarily administered via injection. The FDA recently approved a pill form of semaglutide, Wegovy, marking the first oral GLP-1 medication cleared in the U.S. For weight management. A pill form of semaglutide, Rybelsus, has been available since 2019 for treating diabetes. Another oral GLP-1 drug, orforglipron, is currently under FDA review.
What’s Next for GLP-1s?
The increasing demand for GLP-1 medications is driving research into new formulations and delivery methods. The development of oral medications represents a significant step towards greater patient convenience. However, ongoing monitoring of side effects and long-term health outcomes will be crucial to ensure the safe and effective use of these powerful drugs.
Will Insurance Coverage Expand?
Currently, insurance coverage for Wegovy and Ozempic varies widely. As more data becomes available and the understanding of these medications evolves, insurance policies may adapt to provide broader coverage for eligible patients.
The Role of Lifestyle Changes
Experts emphasize that GLP-1 medications should not be viewed as a quick fix for weight loss. They are most effective when combined with a healthy diet and regular exercise. Sustainable lifestyle changes remain the cornerstone of long-term weight management and overall health.
FAQ
- What is NAION? Non-arteritic anterior ischemic optic neuropathy is a condition that damages the optic nerve, leading to sudden vision loss.
- Are Ozempic and Wegovy the same drug? Both contain semaglutide, but Wegovy is a higher dose approved for weight loss, while Ozempic is approved for type 2 diabetes.
- What are the most common side effects of GLP-1 drugs? Nausea, diarrhea, vomiting, and constipation are the most frequently reported side effects.
- Is there a pill form of Wegovy? Yes, the FDA recently approved a pill form of semaglutide (Wegovy) for weight management.
Pro Tip: Always discuss the potential risks and benefits of any medication with your healthcare provider before starting treatment.
Have you or someone you know experienced side effects from Ozempic or Wegovy? Share your story in the comments below.
